-
2
-
-
1942501149
-
Osteogenesis imperfecta
-
Rauch F, Glorieux FH (2004) Osteogenesis imperfecta. Lancet 363:1377-1385
-
(2004)
Lancet
, vol.363
, pp. 1377-1385
-
-
Rauch, F.1
Glorieux, F.H.2
-
3
-
-
84874706329
-
Osteogenesis imperfecta
-
Glorieux FH, Pettifor J, Jueppner H (eds). Academic Press, San Diego
-
Plotkin H, Primorac D, Rowe D (2003) Osteogenesis imperfecta. In: Glorieux FH, Pettifor J, Jueppner H (eds) Pediatric bone. Academic Press, San Diego, pp 443-471
-
(2003)
Pediatric Bone
, pp. 443-471
-
-
Plotkin, H.1
Primorac, D.2
Rowe, D.3
-
4
-
-
0032190352
-
Cyclic administration of pamidronate in children with severe osteogenesis imperfecta
-
Glorieux FH, Bishop NJ, Plotkin H, Chabot G, Lanoue G, Travers R (1998) Cyclic administration of pamidronate in children with severe osteogenesis imperfecta. N Engl J Med 339:947-952
-
(1998)
N Engl J Med
, vol.339
, pp. 947-952
-
-
Glorieux, F.H.1
Bishop, N.J.2
Plotkin, H.3
Chabot, G.4
Lanoue, G.5
Travers, R.6
-
5
-
-
29644443435
-
Two-year clinical trial of oral alendronate versus intravenous pamidronate in children with osteogenesis imperfecta
-
Di Meglio LA, Peacock M (2006) Two-year clinical trial of oral alendronate versus intravenous pamidronate in children with osteogenesis imperfecta. J Bone Miner Res 21:132-140
-
(2006)
J Bone Miner Res
, vol.21
, pp. 132-140
-
-
Di Meglio, L.A.1
Peacock, M.2
-
6
-
-
0037186926
-
Intravenous zolendronic acid in postmenopausal women with low bone mineral density
-
Reid IR, Brown JP, Burckhardt P, Horowitz Z, Richardson P, Trechsel U et al (2002) Intravenous zolendronic acid in postmenopausal women with low bone mineral density. N Engl J Med 346:653-661
-
(2002)
N Engl J Med
, vol.346
, pp. 653-661
-
-
Reid, I.R.1
Brown, J.P.2
Burckhardt, P.3
Horowitz, Z.4
Richardson, P.5
Trechsel, U.6
-
7
-
-
24044431619
-
Comparison of a single infusion of zoledronic acid with risedronate for Paget's disease
-
Reid IR, Miller P, Lyles K, Fraser W, Brown JP, Saidi Y, Mesenbrink P, Su G, Pak J, Zelenakas K, Luchi M, Richardson P, Hosking D (2005) Comparison of a single infusion of zoledronic acid with risedronate for Paget's disease. N Engl J Med 353:898-908
-
(2005)
N Engl J Med
, vol.353
, pp. 898-908
-
-
Reid, I.R.1
Miller, P.2
Lyles, K.3
Fraser, W.4
Brown, J.P.5
Saidi, Y.6
Mesenbrink, P.7
Su, G.8
Pak, J.9
Zelenakas, K.10
Luchi, M.11
Richardson, P.12
Hosking, D.13
-
8
-
-
47149118386
-
Normalization of bone markers is associated with improved survival in patients with bone metastases from solid tumors and elevated bone resorption receiving zoledronic acid
-
Lipton A, Cook R, Saad F, Major P, Garnero P, Terpos E, Brown JE, Coleman RE (2008) Normalization of bone markers is associated with improved survival in patients with bone metastases from solid tumors and elevated bone resorption receiving zoledronic acid. Cancer 113:193-201
-
(2008)
Cancer
, vol.113
, pp. 193-201
-
-
Lipton, A.1
Cook, R.2
Saad, F.3
Major, P.4
Garnero, P.5
Terpos, E.6
Brown, J.E.7
Coleman, R.E.8
-
9
-
-
21344452794
-
Bisphosphonate treatment in osteogenesis imperfecta: Which drug, for whom, for how long?
-
Rauch F, Glorieux FH (2005) Bisphosphonate treatment in osteogenesis imperfecta: which drug, for whom, for how long? Ann Med 37:295-302
-
(2005)
Ann Med
, vol.37
, pp. 295-302
-
-
Rauch, F.1
Glorieux, F.H.2
-
10
-
-
0025138995
-
Consistent linkage of dominantly inherited osteogenesis imperfecta to the type i collagen loci: COL1A1 and COL1A2
-
Sykes B, Ogilvie D, Wordsworth P, Wallis G, Mathew C, Beightn P, Nicolls A, Pope FM, Thompson E, Tsipouras P, Schwartz R, Jensson O, Arnason A, Børresen AL, Heiberg A, Frey D, Steinmann B (1990) Consistent linkage of dominantly inherited osteogenesis imperfecta to the type I collagen loci: COL1A1 and COL1A2. Am J Hum Genet 46:293-307
-
(1990)
Am J Hum Genet
, vol.46
, pp. 293-307
-
-
Sykes, B.1
Ogilvie, D.2
Wordsworth, P.3
Wallis, G.4
Mathew, C.5
Beightn, P.6
Nicolls, A.7
Pope, F.M.8
Thompson, E.9
Tsipouras, P.10
Schwartz, R.11
Jensson, O.12
Arnason, A.13
Børresen, A.L.14
Heiberg, A.15
Frey, D.16
Steinmann, B.17
-
12
-
-
61849099801
-
Safety and efficacy of intravenous zolendronic acid in paediatric osteoporosis
-
Brown JJ, Zacharin MR (2009) Safety and efficacy of intravenous zolendronic acid in paediatric osteoporosis. J Pediatr Endocrinol Metab 22:55-63
-
(2009)
J Pediatr Endocrinol Metab
, vol.22
, pp. 55-63
-
-
Brown, J.J.1
Zacharin, M.R.2
-
13
-
-
0344664559
-
Zoledronic acid: A new parenteral bisphosphonate
-
Li EC, Davis LE (2003) Zoledronic acid: a new parenteral bisphosphonate. Clin Ther 25:2669-2708
-
(2003)
Clin Ther
, vol.25
, pp. 2669-2708
-
-
Li, E.C.1
Davis, L.E.2
-
15
-
-
0028359009
-
Bone mineral content and density in healthy subjects and in osteogenesis imperfecta
-
Davie MW, Haddaway MJ (1994) Bone mineral content and density in healthy subjects and in osteogenesis imperfecta. Arch Dis Child 70:331-334
-
(1994)
Arch Dis Child
, vol.70
, pp. 331-334
-
-
Davie, M.W.1
Haddaway, M.J.2
-
16
-
-
0031974976
-
Differing lumbar vertebral mineralization rates in ambulatory pediatric patients with osteogenesis imperfecta
-
Reinus WR, McAlister WH, Schranck F, Chines A, Whyte MP (1998) Differing lumbar vertebral mineralization rates in ambulatory pediatric patients with osteogenesis imperfecta. Calcif Tissue Int 62:17-20
-
(1998)
Calcif Tissue Int
, vol.62
, pp. 17-20
-
-
Reinus, W.R.1
McAlister, W.H.2
Schranck, F.3
Chines, A.4
Whyte, M.P.5
-
17
-
-
0026602260
-
Osteogenesis imperfecta: A clinical study of the first ten years of life
-
Vetter U, Pontz B, Zauner E, Brenner RE, Spranger J (1992) Osteogenesis imperfecta: a clinical study of the first ten years of life. Calcif Tissue Int 50:36-41
-
(1992)
Calcif Tissue Int
, vol.50
, pp. 36-41
-
-
Vetter, U.1
Pontz, B.2
Zauner, E.3
Brenner, R.E.4
Spranger, J.5
|